Header Logo

Connection

Philip Liebson to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Treatment Outcome.
Philip Liebson
Connection Strength
0.150
Treatment Outcome
  1. Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
    View in: PubMed
    Score: 0.043
  2. ENHANCE and ONTARGET. Prev Cardiol. 2008; 11(3):179-82.
    View in: PubMed
    Score: 0.040
  3. Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec; 7(17):2385-401.
    View in: PubMed
    Score: 0.037
  4. LIFE and ARBITER. Prev Cardiol. 2003; 6(2):108-11.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.